Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 7, 2017; 23(5): 891-898
Published online Feb 7, 2017. doi: 10.3748/wjg.v23.i5.891
Published online Feb 7, 2017. doi: 10.3748/wjg.v23.i5.891
Table 1 Baseline demographics
Subjects | n = 36 |
Sex, F/M | 12/24 |
Age, median (range) | 71 (48-86) |
Underlying disease | |
Perforation | |
Gastric | 1 |
Small intestine | 2 |
Colo/rectal | 8 |
Abscess/bacteremia | 12 |
Ileus | 3 |
Pancreatitis | 2 |
Pneumonia | 5 |
Drug-induced | 3 |
Peri-operative, no/yes | 10/26 |
Cancer-associated, no/yes | 23/13 |
Post-operative day, ≤ 7/> 7 | 21/5 |
Combination treatment for DIC | |
Unfractionated heparins | 4 |
Anti-thrombin concentrates | 28 |
γ-globulin agents | 29 |
Vasopressors | 26 |
Protease inhibitors | 4 |
Sivelestat sodium hydrates | 4 |
Steroid preparations | 7 |
Dialysis | 5 |
Blood transfusion | 4 |
- Citation: Konishi H, Okamoto K, Shoda K, Arita T, Kosuga T, Morimura R, Komatsu S, Murayama Y, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Otsuji E. Early thrombomodulin-α administration outcome for acute disseminated intravascular coagulopathy in gastrointestinal surgery. World J Gastroenterol 2017; 23(5): 891-898
- URL: https://www.wjgnet.com/1007-9327/full/v23/i5/891.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i5.891